Cross Country Healthcare buy melinda
Start price
05.09.12
/
50%
€3.54
Target price
05.03.13
€4.00
Performance (%)
23.42%
End price
05.03.13
€4.36
Summary
This prediction ended on 05.03.13 with a price of €4.36. The prediction had a final performance of 23.42%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cross Country Healthcare | 1.220% | 1.220% | -42.361% | -61.927% |
| iShares Core DAX® | -1,10 % | -6,08 % | 3,20 % | 53,31 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 20,24 % | 93,48 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 27,55 % | 52,32 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 14,89 % | 66,74 % |
Comments by melinda for this prediction
In the thread Cross Country Healthcare diskutieren
klinischen Studien
Langlauf und Gesundheitsdienstleister von klinischen Studien andere Dienste Human Capital Management konzentriert sich auf Gesundheits-
(Laufzeit überschritten)
Stopped prediction by melinda for Cross Country Healthcare
Cross Country Healthcare
Start price
Target price
Perf. (%)
€7.30
21.12.13
21.12.13
€5.50
23.06.14
23.06.14
-34.93%
23.06.14
23.06.14
